P&G, Health

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

07.08.2025 - 18:08:39

P&G Health Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen Singapore

1 in 2 Diabetics and 1 in 10 Pre-diabetics estimated to suffer from Peripheral NeuropathyVitamin B Deficiency affects quality of life of ~ 19% of all people with diabetes#KnowtheSigns leverages Artificial Intelligence to make the invisible condition of Peripheral Neuropathy & Vitamin B deficiency visible and more relatable to consumersprovides consumers a simple and quick self-assessment to check for symptoms and understand when to contact a healthcare practitioner.

"We will also be organizing #KnowtheSigns scientific events with leading Health Experts to create awareness on the importance of identifying signs of Peripheral Neuropathy and Vitamin B Deficiency in patients, diagnosing high-risk patients, and latest guidelines in management including the role of high dose B Vitamins in treatment." Aalok Agrawal added.

#KnowtheSigns will be live all of November across on-ground and digital touchpoints in Philippines, Indonesia, India, Singapore, Malaysia, Thailand, UAE, Saudi Arabia, and South Africa in collaboration with healthcare professionals, medical organizations, influencers, partners, consumers, and patients. For more information on the campaign, please write to our media contacts.

Disclaimer: Indications of Neurobion may differ in different countries, please check with your local healthcare professionals for more information.

About P&G Health:
P&G Health, the health care division of P&G company, drives consumer-centric innovation to empower our consumers to live healthier, and more vibrant lives. The P&G Health portfolio includes leading brands in Respiratory with Vicks® and Nasivin®, Pregnancy with Femibion® and Clearblue®, Oral Care with Crest® and Oral-B®, Vitamins and Minerals Supplementation with Bion3®, Seven Seas®, Evion® and Sangobion®, Digestive wellness with Metamucil®, Prilosec OTC®, Pepto Bismol® and Align®, Nerve Care with Neurobion® and Pain Relief with Dolo-Neurobion®.

About Procter & Gamble:
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.

References:
1.     Landmann G. Ars Medici. 2013;1: 18-21
2.     Kumar S, et al. Laser Therapy 2016;25: 141–144
3.     Ziegler D et al. Neuropathy in prediabetes. Diabetes Metab Res Rev. 2023
4.     Nix WA et al. Diabetes Res Clin Pract 2015; 107:157–165.
5.     Adaikalakoteswari A et al. Diabetes Res Clin Pract 2012; 95:415–424.

Photo - https://mma.prnewswire.com/media/2260998/Image_credit_P_G_Health.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/pg-health-commemorates-world-diabetes-day-2023-with-innovative-ai-based-experiential-campaign-knowthesigns-301972794.html

@ prnewswire.co.uk